Author:
Lee Wen-Jane,Lin Keng-Hung,Wang Jun-Sing,Sheu Wayne Huey-Herng,Shen Chin-Chang,Yang Cheng-Ning,Wu Sheng-Mao,Shen Li-Wei,Lee Shu-Hua,Lai De-Wei,Lan Keng-Li,Tung Chun-Wei,Liu Shing-Hwa,Sheu Meei-Ling
Subject
Pharmacology,General Medicine
Reference55 articles.
1. Diabetic retinopathy;Antonetti;N. Engl. J. Med.,2012
2. TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy;Lai;Circ. Res.,2017
3. Therapeutic potential of Tpl2 (tumor progression locus 2) inhibition on diabetic vasculopathy through the blockage of the inflammasome complex;Sheu;Arterioscler. Thromb. Vasc. Biol.,2021
4. Diabetic retinopathy;Wong;Nat. Rev. Dis. Prim.,2016
5. Evaluation and care of patients with diabetic retinopathy;Jampol;N. Engl. J. Med.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献